No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.

Rebecca Lajaunie Lise CuzinRomain PalichAlain Makinson Firouzé Bani-SadrClaudine DuvivierCedric ArvieuxDavid ReyIsabelle Poizot-MartinCyril DelpierrePierre DelobelGuillaume Martin-Blondelnull null

Published in: HIV medicine (2021)

In this large cohort of PLHIV with a history of KS and ART-controlled HIV replication, KS relapses were described in 3.2% of the patients, and were not more frequent when a PI-containing ART regimen has been switched to a PI-free regimen. Our results do not support a specific effect of PI on KS.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
hiv infected patients
hiv aids
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
hepatitis c virus